{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:48Z","timestamp":1772165748336,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The optimal chest wall bolus regimen for postmastectomy radiotherapy (PMRT) remains unknown. We aimed to prospectively evaluate the use of a 1-mm-thick daily tissue-equivalent bolus in patients who received PMRT using thermoluminescent dosimeters (TLDs) and skin toxicity assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with a 1-mm-thick daily bolus during PMRT were prospectively enrolled at The Juntendo University Hospital. The surface dose was measured in vivo under the 1-mm-thick bolus on the chest wall. We assessed the acute skin toxicity weekly during PMRT, and 1, 2, 4, and 12\u2009weeks after the completion of PMRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 19 patients aged 32\u201379\u2009years old received PMRT from July 2019 to January 2020. All patients completed the protocol treatment without interruptions, and the median follow-up was 32\u2009weeks. In vivo dosimetry analysis revealed surface doses between 77 and 113% of the prescribed dose, with a mean of 92% of the prescribed radiation dose, and a standard deviation of 7% being delivered. Grade 2 dermatitis was found in 10 patients (53%), and Grade 3 dermatitis was found in one patient (5%). All cases of Grade 2 and 3 dermatitis were improved 4\u2009weeks after PMRT. There were no cases of Grade 4 dermatitis and no chest wall recurrences during the treatment or follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Results confirmed the feasibility of using a 1-mm-thick daily bolus for PMRT, exhibiting an appropriate dose buildup and acceptable skin toxicity without treatment interruptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The University Hospital Medical Information Network Clinical Trials Registry,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/upload.umin.ac.jp\/cgi-openbin\/ctr_e\/ctr_view.cgi?recptno=R000040622\">UMIN000035773<\/jats:ext-link>\n                      . Registered 1 July 2019.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-07851-3","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T08:13:44Z","timestamp":1612253624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A prospective feasibility study of a 1-mm bolus for postmastectomy radiotherapy"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-5577","authenticated-orcid":false,"given":"Terufumi","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Shikama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"issue":"3","key":"7851_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0360-3016(03)00112-3","volume":"56","author":"SJ Feigenberg","year":"2003","unstructured":"Feigenberg SJ, Price Mendenhall N, Benda RK, Morris CG. Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons. Int J Rad Oncol Biol Phys. 2003;56(3):716\u201325.","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"9503","key":"7851_CR2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England). 2005;366(9503):2087\u2013106.","journal-title":"Lancet (London, England)"},{"issue":"9935","key":"7851_CR3","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (London, England). 2014;383(9935):2127\u201335.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"7851_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canrad.2017.07.051","volume":"22","author":"L Cao","year":"2018","unstructured":"Cao L, Ou D, Shen KW, Cai G, Cai R, Xu F, Zhao SG, Xu C, Grellier Adedjouma N, Kirova YM, et al. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer. Cancer Radiother. 2018;22(1):38\u201344.","journal-title":"Cancer Radiother"},{"issue":"2","key":"7851_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.clon.2006.10.004","volume":"19","author":"TT Vu","year":"2007","unstructured":"Vu TT, Pignol JP, Rakovitch E, Spayne J, Paszat L. Variability in radiation oncologists' opinion on the indication of a bolus in post-mastectomy radiotherapy: an international survey. Clin Oncol. 2007;19(2):115\u20139.","journal-title":"Clin Oncol"},{"issue":"4","key":"7851_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.prro.2012.09.004","volume":"3","author":"RC Blitzblau","year":"2013","unstructured":"Blitzblau RC, Horton JK. Treatment planning technique in patients receiving postmastectomy radiation therapy. Pract Rad Oncol. 2013;3(4):241\u20138.","journal-title":"Pract Rad Oncol"},{"issue":"1","key":"7851_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clbc.2014.07.005","volume":"15","author":"J Mayadev","year":"2015","unstructured":"Mayadev J, Einck J, Elson S, Rugo H, Hwang S, Bold R, Daroui P, McCloskey S, Yashar C, Kim D, et al. Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. Clin Breast Cancer. 2015;15(1):43\u20137.","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"7851_CR8","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/j.ijrobp.2011.01.002","volume":"81","author":"MT Tieu","year":"2011","unstructured":"Tieu MT, Graham P, Browne L, Chin YS. The effect of adjuvant postmastectomy radiotherapy bolus technique on local recurrence. Int J Rad Oncol Biol Phys. 2011;81(3):e165\u201371.","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"7851_CR9","doi-asserted-by":"publisher","unstructured":"Kawamoto T, Shikama N, Kurokawa C, Hara N, Oshima M, Sasai K. Dosimetric assessment of bolus for postmastectomy radiotherapy. Med Dosim. 2020;S0958-3947(20)30125-4.\u00a0 https:\/\/doi.org\/10.1016\/j.meddos.2020.08.001. Online ahead of print.","DOI":"10.1016\/j.meddos.2020.08.001"},{"issue":"3","key":"7851_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prro.2016.10.015","volume":"7","author":"LC Das","year":"2017","unstructured":"Das LC, Golden DW, Perevalova E, Wong AC, De Nardo K, Stepaniak C, Joyce DS, McCabe BP, Hasan Y, Chmura SJ, et al. A feasibility study of 2-mm bolus for postmastectomy radiation therapy. Pract Rad Oncol. 2017;7(3):161\u20136.","journal-title":"Pract Rad Oncol"},{"key":"7851_CR11","unstructured":"National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf\u00a0"},{"issue":"2","key":"7851_CR12","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.prro.2012.05.009","volume":"3","author":"E Healy","year":"2013","unstructured":"Healy E, Anderson S, Cui J, Beckett L, Chen AM, Perks J, Stern R, Mayadev J. Skin dose effects of postmastectomy chest wall radiation therapy using brass mesh as an alternative to tissue equivalent bolus. Pract Rad Oncol. 2013;3(2):e45\u201353.","journal-title":"Pract Rad Oncol"},{"issue":"1037","key":"7851_CR13","doi-asserted-by":"publisher","first-page":"20140035","DOI":"10.1259\/bjr.20140035","volume":"87","author":"C Ordonez-Sanz","year":"2014","unstructured":"Ordonez-Sanz C, Bowles S, Hirst A, MacDougall ND. A single plan solution to chest wall radiotherapy with bolus? Br J Radiol. 2014;87(1037):20140035.","journal-title":"Br J Radiol"},{"issue":"1","key":"7851_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijrobp.2014.09.022","volume":"91","author":"JP Pignol","year":"2015","unstructured":"Pignol JP, Vu TT, Mitera G, Bosnic S, Verkooijen HM, Truong P. Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy. Int J Rad Oncol Biol Phys. 2015;91(1):157\u201364.","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"2","key":"7851_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijrobp.2014.06.042","volume":"90","author":"JL Wright","year":"2014","unstructured":"Wright JL, Takita C, Reis IM, Zhao W, Lee E, Hu JJ. Racial variations in radiation-induced skin toxicity severity: data from a prospective cohort receiving postmastectomy radiation. Int J Rad Oncol Biol Phys. 2014;90(2):335\u201343.","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"7851_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.breast.2015.09.005","volume":"27","author":"YF Li","year":"2016","unstructured":"Li YF, Chang L, Li WH, Xiao MY, Wang Y, He WJ, Xia YX, Wang L, Chen Y. Radiotherapy concurrent versus sequential with endocrine therapy in breast cancer: A meta-analysis. Breast. 2016;27:93\u20138.","journal-title":"Breast"},{"issue":"2","key":"7851_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.radonc.2017.07.006","volume":"124","author":"F Mignot","year":"2017","unstructured":"Mignot F, Ajgal Z, Xu H, Geraud A, Chen JY, M\u00e9gnin-Chanet F, Kirova Y. Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic review. Radiother Oncol. 2017;124(2):190\u20139.","journal-title":"Radiother Oncol"},{"issue":"2","key":"7851_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ijrobp.2018.02.006","volume":"101","author":"AY Ho","year":"2018","unstructured":"Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A, Arnold BB, Porinchak M, Lacouture M, McCormick B, et al. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation. Int J Rad Oncol Biol Phys. 2018;101(2):325\u201333.","journal-title":"Int J Rad Oncol Biol Phys"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07851-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-021-07851-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07851-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T08:16:07Z","timestamp":1612253767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07851-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7851"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07851-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-130273\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-81403\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-81403\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the ethics committee of The Juntendo University Hospital (approval number: 19\u2013087). The study was conducted in accordance with the principles laid out in the Declaration of Helsinki and in accordance with the principles of Good Clinical Practice. Written informed consent was obtained from all participants in our study. This study has been registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN000035773).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}